FAU recently hosted the Third Sea-level Rise Summit with more than 250 participants in attendance. The conference featured experts from the public and private sectors, as well as scientists and researchers.
Just as parts of South Florida are bracing for potential flooding risks in low-lying areas, FAU is leading efforts to bring together professionals to help identify solutions and develop adaptation pathways.
Just as the sun sets, hundreds of groupers gather at their favorite hangouts along the shelf breaks in the southeast U.S., Gulf of Mexico and the Caribbean Basin to spawn – and they’re pretty vocal about it.
There are currently no medications available to specifically treat Lewy Body dementia (LBD). FAU's College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for LBD.
A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
The sub-tropics and the Arctic are rarely discussed together, and comparing shared experiences is expected to unlock new insights and generate a blueprint for solutions and adaptation.
A professor has identified 55 drug targets for the Zika virus from the human genome, leading to the identification of 79 FDA-approved drugs currently being used to treat other conditions such as cancer.
Research funded by a grant from the Bonefish & Tarpon Trust will design and test experimental means of growning bonefish for stock enhancement.
A psychology professor will continue a unique longitudinal study of bilingual development in children, focusing on language, literacy, cognitive growth, and academic achievement for Spanish-speaking children.